ASMED® at the 24th SEMAL Congress in Madrid, 1-3 October 2026

From 1 to 3 October, ASMED® is exhibiting at the 24th SEMAL congress on anti-ageing and longevity medicine in Madrid: Sala Liria, stand no. 12.

The efficacy of REAC® Technology in managing depression, anxiety and stress: evidence from the DASS-42 study

REAC-NPO and REAC-NPPO neurobiological modulation treatments in the management of anxiety, depression and stress.

A randomized cross-over study evaluates the feasibility, safety and motor effects of the REAC® NPO protocol in 60 patients.

Analysis of the clinical results of the PMCF study on the REAC ACT, CO and MO-IBZ protocols.

Biomodulation protocols ACT, CO and MO based on REAC® Technology presented at the congress.

Evidence on the technology in children with behavioural disorders, presented within the framework of the new European guide.